Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 158 INDUSTRY 109 NETWORK 8 NIH 5 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

spartalizumab 2 Rituximab 2 tislelizumab 1 pegylated granulocyte colony-stimulating factor 1 pegaspargase 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Oxaliplatin 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lenalidomide 1 Idarubicin 1 Gemcitabine 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Bendamustine Hydrochloride × Lymphoid × Clear all

NCT01412307 2015-08-11

LEBEN

GiovanniPascale

Phase 1/2 Unknown

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡